Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

Presentation TVT 2019

Towards Simplifying the Workflow for Transcatheter Left Atrial Appendage Closure Using Preprocedural CT Planning and Intraprocedural Left Atrial Volume Intracardiac Echocardiography

Presenter: Vivian Ng

June 14, 2019

Presentation TVT 2019

Lessons From the Global Aortic VIVID Registry: Optimizing Procedural Outcomes

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Updates on SAPIEN Balloon-Expandable VIV

Presenter: John Webb

June 13, 2019

Presentation TVT 2019

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Presenter: Jeffrey Popma

June 13, 2019

Presentation TVT 2019

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Presenter: Danny Dvir

June 13, 2019

Presentation TVT 2019

Late-Presenting Migration of Sapien XT Into LVOT Treated With TF-VIV

Presenter: Jason Ricci

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2019

A Tutorial on Surgical Bioprosthesis Design: Impact on VIV Therapy

Presenter: Vinayak Bapat

June 13, 2019

Advertisement

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Towards Simplifying the Workflow for Transcatheter Left Atrial Appendage Closure Using Preprocedural CT Planning and Intraprocedural Left Atrial Volume Intracardiac Echocardiography

Lessons From the Global Aortic VIVID Registry: Optimizing Procedural Outcomes

Updates on SAPIEN Balloon-Expandable VIV

Updates From the CoreValve and EVOLUT R Aortic VIV Registries

Splitting Leaflets. BASILICA to Reduce the Risk of Coronary Obstruction During VIV (and Other TAVR) Procedures

Late-Presenting Migration of Sapien XT Into LVOT Treated With TF-VIV

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

A Tutorial on Surgical Bioprosthesis Design: Impact on VIV Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content